APPLICATION SITE MACULE

APPLICATION SITE MACULE was reported 15 times

APPLICATION SITE MACULE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Nonergot Dopamine Agonist [EPC] 1 0.0001
1 Cholinesterase Inhibitor [EPC] 1 0.0001
2 Arteriolar Vasodilator [EPC] 3 0.0000
3 Provitamin D2 Compound [EPC] 1 0.0000
4 5-alpha Reductase Inhibitor [EPC] 3 0.0000
5 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
6 Integrin Receptor Antagonist [EPC] 1 0.0000
7 Alkylating Drug [EPC] 1 0.0000
8 Vitamin B12 [EPC] 1 0.0000
9 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
10 Platelet Aggregation Inhibitor [EPC] 1 0.0000
11 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
12 Corticosteroid [EPC] 1 0.0000